Invivyd (IVVD) Accumulated Expenses (2020 - 2025)
Invivyd (IVVD) reported Accumulated Expenses of $19.1 million for Q4 2025, down 62.04% on a YoY basis from $50.2 million in Q4 2024, and down 24.62% quarter-over-quarter from $25.3 million in Q3 2025.
Invivyd (IVVD) Accumulated Expenses (2020 - 2025) Analysis & Trends
Invivyd has reported Accumulated Expenses for 6 years, with the latest figure at $19.1 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses fell 62.04% year-over-year to $19.1 million; the trailing twelve-month figure through Dec 2025 stood at $19.1 million (down 62.04% YoY), and the FY2025 full-year result was $19.1 million, down 62.04% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $19.1 million, down from $25.3 million in the prior quarter.
- The five-year high for Accumulated Expenses was $76.5 million in Q1 2022, with the low at $14.5 million in Q1 2023.
- Historically, Accumulated Expenses has averaged $35.6 million across 5 years, with a median of $29.0 million in 2022.
- Annual changes were most pronounced in 2021 — Accumulated Expenses jumped 1044.07% — and 2023, when it tumbled 81.05%.
- Invivyd's Accumulated Expenses stood at $56.3 million in 2021, then slumped by 61.07% to $21.9 million in 2022, then surged by 86.48% to $40.9 million in 2023, then increased by 22.85% to $50.2 million in 2024, then tumbled by 62.04% to $19.1 million in 2025.
- The last three Accumulated Expenses figures came in at $19.1 million (Q4 2025), $25.3 million (Q3 2025), and $25.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.05 Mn |
| Sep 30, 2025 | 25.28 Mn |
| Jun 30, 2025 | 25.31 Mn |
| Mar 31, 2025 | 39.93 Mn |
| Dec 31, 2024 | 50.20 Mn |
| Sep 30, 2024 | 59.40 Mn |
| Jun 30, 2024 | 26.82 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 40.86 Mn |
| Sep 30, 2023 | 15.96 Mn |
| Jun 30, 2023 | 26.74 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 21.91 Mn |
| Sep 30, 2022 | 28.97 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 76.54 Mn |
| Dec 31, 2021 | 56.28 Mn |
| Sep 30, 2021 | 35.49 Mn |
| Jun 30, 2021 | 27.18 Mn |
| Dec 31, 2020 | 4.92 Mn |